Focused Wealth Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-800
Closed -$768 1125
2023
Q2
$768 Hold
800
﹤0.01% 912
2023
Q1
$600 Hold
800
﹤0.01% 920
2022
Q4
$295 Hold
800
﹤0.01% 993
2022
Q3
$0 Hold
800
﹤0.01% 1095
2022
Q2
$1K Hold
800
﹤0.01% 902
2022
Q1
$1K Hold
800
﹤0.01% 964
2021
Q4
$1K Hold
800
﹤0.01% 958
2021
Q3
$2K Hold
800
﹤0.01% 845
2021
Q2
$3K Buy
+800
New +$2.78K ﹤0.01% 802
2020
Q1
Sell
-4,000
Closed -$15K 804
2019
Q4
$15K Hold
4,000
﹤0.01% 456
2019
Q3
$33K Hold
4,000
0.01% 338
2019
Q2
$34K Hold
4,000
0.01% 360
2019
Q1
$43K Hold
4,000
0.01% 302
2018
Q4
$35K Hold
4,000
0.01% 330
2018
Q3
$67K Hold
4,000
0.02% 267
2018
Q2
$84K Hold
4,000
0.03% 239
2018
Q1
$64K Hold
4,000
0.02% 276
2017
Q4
$76K Hold
4,000
0.02% 258
2017
Q3
$56K Hold
4,000
0.02% 223
2017
Q2
$30K Hold
4,000
0.01% 340
2017
Q1
$26K Hold
4,000
0.01% 349
2016
Q4
$18K Hold
4,000
0.01% 396
2016
Q3
$19K Hold
4,000
0.01% 373
2016
Q2
$26K Buy
+4,000
New +$28.3K 0.01% 322
2016
Q1
Sell
-4,000
Closed -$24K 728
2015
Q4
$24K Buy
+4,000
New +$22.9K 0.01% 303
2015
Q2
Sell
-4,000
Closed -$24K 715
2015
Q1
$24K Buy
+4,000
New +$26.6K 0.01% 295

Focused Wealth Management's SPPI Position: Q3 2023 in Review

Focused Wealth Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 800 shares — an estimated $768 sold.

Focused Wealth Management first reported a position in SPPI in Q1 2015 and held it in 26 quarters. The position peaked at $84K in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Focused Wealth Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Focused Wealth Management sold 800 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $768.
  • Focused Wealth Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 26 quarters.
  • Focused Wealth Management's Spectrum Pharmaceuticals Inc position peaked at $84K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Focused Wealth Management's 13F filing for Q3 2023, filed 1 Nov 2023.